Concurrent Group IV

ISSCR 2018 Plenary and Concurrent

3 - INHIBITION OF ROR1 STEM CELL SIGNALING BY CIRMTUZUMAB IN CHRONIC LYMPHOCYTIC LEUKEMIA: PHASE 1 CLINICAL TRIAL RESULTS.

6/23/2018
13:45 - 14:00

Reilly L. Kidwell

Moores Cancer Center, University of California San Diego, CA, United States

Presentation(s):

Send Email for Reilly Kidwell


Assets

3 - INHIBITION OF ROR1 STEM CELL SIGNALING BY CIRMTUZUMAB IN CHRONIC LYMPHOCYTIC LEUKEMIA: PHASE 1 CLINICAL TRIAL RESULTS.



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for INHIBITION OF ROR1 STEM CELL SIGNALING BY CIRMTUZUMAB IN CHRONIC LYMPHOCYTIC LEUKEMIA: PHASE 1 CLINICAL TRIAL RESULTS.